After years of aggressive expansion, many Medicare Advantage plans are recalibrating popular extras and changing costs.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
Science Corp., a brain-implant startup developing a device that can enable blind people to see again, just raised $230 million from investors.
If the accounts come to fruition, they could achieve a longtime goal of industry advocates and policymakers on both sides of the aisle.
Out-of-pocket care expenses for a healthy couple are near $1 million, and federal policy proposals could soon make matters worse.
Just last week, the agency rejected Moderna’s initial application, citing flaws in the company’s research design.
Large language models are not only reshaping recruiting and hiring methods but also how workers approach retirement savings and planning.
While P&G has seen low demand for a wide swath of products, not everything in its portfolio was in the red.
While 2025’s IPO boom is likely being enjoyed by Wall Street’s investment bankers, it may be even better news for private equity.
With the average cost of health care regularly outpacing inflation, Americans are struggling to afford it.
The firm expects Big Tech’s dominance to level out, with smaller companies that are utilizing AI starting to gain more investor interest.
Earlier this month, Exact reported a record $851 million in third-quarter revenue, which included $666 million from its screening business.
J&J this year lost its patent exclusivity for Stelara, its longtime top-selling drug that treats psoriasis and inflammatory bowel disease.
AI functions as a sidekick in healthcare labs, but it can make a huge difference by accelerating drug development and boosting data accuracy.
Microsoft wants to patent a system that thinks, acts and checks its results while handling patient data and working within hospital systems.
Pangaea Data’s new platform aims to improve medical treatments by informing doctors of patients’ health histories and potential diagnoses.
Studies exploring whether there’s a connection between Tylenol’s key ingredient acetaminophen and autism have had mixed results.